跳至主要内容
临床试验/ISRCTN25867281
ISRCTN25867281未知未知

Genetic Polymorphisms and Weight Loss in Obesity: A Randomised Trial of Hypo-Energetic High- versus Low-Fat Diets

European Commission, Research Directorate-General (Belgium)0 个研究点目标入组 755 人开始时间: 2006年5月4日最近更新:
适应症

试验速览

阶段
未知
发起方
入组人数
755

研究概览

简要总结

2006 Results article in http://www.ncbi.nlm.nih.gov/pubmed/16871334 results 2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/22952648 results

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Body mass index (BMI) =30
  • 2. White European (by self report)
  • 3. Age 20-50 years
  • 4. Pre-menopausal (women)

排除标准

  • 1. Drug-treated hypertension
  • 2. Drug-treated diabetes
  • 3. Drug-treated hyperlipidaemia
  • 4. Drug-treated thyroid disease
  • 5. Use of anorexigenic agents
  • 6. Anti-epileptic drugs
  • 7. Anti-Parkinsonian drugs
  • 8. Use of barbituates, benzodiasapines, beta-blockers, butyrophenones, carbonic anhydrase inhibitors, diuretics, dopamine reuptake inhibitors, digoxin, fibrates, fish oil supplement, glucocorticoids, immunosuppressives, insulin , laxatives, monoamine oxidase (MAO) inhibitors, niacin (>150 mg per day), nicotine, oral hypoglycemics, orlistat, phenothiazines, selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, statins, thyroid hormone, triamterene, tricyclic antidepressants, warfarin or zonisamide
  • 9. Surgically-treated obesity
  • 10. Participation in ongoing drug trials
  • 11. Pregnant women
  • 12. Alcohol or drug abuse
  • 13. Weight change of >3 kg within 3 months prior to clinical investigation day

研究者

发起方
European Commission, Research Directorate-General (Belgium)

相似试验